Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|HER2 Positive Breast Cancer|Metastatic Breast Cancer|Cancer of the Breast
Interventions: DRUG: IPI-504|DRUG: Trastuzumab
Sponsor: Infinity Pharmaceuticals, Inc.